EUVIMEDEUVIMED entdecken
Crossref

Targeting glycolytic GARP+ fibroblasts alleviates B cell-Th2 crosstalk-driven fibrosis in pancreatic adenocarcinoma

Mahepali Mahabati, Wen-Jie Cao, Zhi-Wei Jian, Yu-Hui Feng, Yi-Zheng Ren, Yong-Yi Wu, Hong-Fei Jiang, Rui-Qi Wu, Cai-Yuan Wu, Chun-Xiang Huang, Xiang-Ming Lao, Yuan Wei

Cancer Communications · 16.11.2026

DOI: 10.34133/cancomm.0077 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Communications, online erschienen am 16.11.2026. Verfasst von Mahepali Mahabati und 11 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Mahabati, M., Cao, W., Jian, Z., Feng, Y., Ren, Y., Wu, Y., Jiang, H., Wu, R., Wu, C., Huang, C., Lao, X., & Wei, Y. (2026). Targeting glycolytic GARP+ fibroblasts alleviates B cell-Th2 crosstalk-driven fibrosis in pancreatic adenocarcinoma. Cancer Communications. https://doi.org/10.34133/cancomm.0077

Vancouver

Mahabati M, Cao W, Jian Z, Feng Y, Ren Y, Wu Y, et al. Targeting glycolytic GARP+ fibroblasts alleviates B cell-Th2 crosstalk-driven fibrosis in pancreatic adenocarcinoma. Cancer Communications. 2026. doi:10.34133/cancomm.0077

BibTeX
@article{Mahabati2026,
  author = {Mahabati, Mahepali and Cao, Wen-Jie and Jian, Zhi-Wei and Feng, Yu-Hui and Ren, Yi-Zheng and Wu, Yong-Yi and Jiang, Hong-Fei and Wu, Rui-Qi and Wu, Cai-Yuan and Huang, Chun-Xiang and Lao, Xiang-Ming and Wei, Yuan},
  title = {Targeting glycolytic GARP+ fibroblasts alleviates B cell-Th2 crosstalk-driven fibrosis in pancreatic adenocarcinoma},
  journal = {Cancer Communications},
  year = {2026},
  doi = {10.34133/cancomm.0077}
}
Kostenlos starten →